Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Bottelli
The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi
Haematologica
Hematology
Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Comprehensive Geriatric Assessment Is an Essential Tool to Support Treatment Decisions in Elderly Patients With Diffuse Large B-Cell Lymphoma: A Prospective Multicenter Evaluation in 173 Patients by the Lymphoma Italian Foundation (FIL)
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Impact of Comorbidities on Outcomes of Elderly Patients With Diffuse Large B-Cell Lymphoma
American Journal of Hematology
Hematology
Efficacy and Tolerability of Anthracycline-Based Therapy in Elderly Patients With Diffuse Large B-Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Comprehensive Geriatric Assessment and Treatment of Elderly Diabetic Patients.
Japanese Journal of Geriatrics
Gerontology
Geriatrics
Non-Anthracycline Chemotherapy Associated With a Poor Outcome in Elderly Egyptian Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
Journal of Cancer Metastasis and Treatment
O3-3-2An Effect of Comprehensive Geriatric Assessment in Elderly Patients With Non-Hodgkin Lymphoma Treated With Chemotherapy
Annals of Oncology
Medicine
Oncology
Hematology
Treatment of Diffuse Large B-Cell Lymphoma in Elderly Patients; Replacing Doxorubicin With Either Epirubicin or Etoposide (VP-16)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
